Prof Daniela Traini gives prestigious Annual Lecture at Drug Delivery to the Lungs 2023

It is with great pleasure to announce, Daniela Traini, Ab Initio’s Non-Executive Director & Scientific Co-Founder presented the annual opening lecture & plenary at Drug Delivery to the Lungs 2023, in Edinburgh, UK. The DDL Lecture is a prestigious accolade bestowed on individuals who have contributed much to the field of respiratory science. Daniela Traini has. more than 25 years experience in pharmaceutical sciences with a focus on aerosol medicine. She is a current NHMRC Investigator (2020-2024) and past ARC Future Fellow (2012-2016), holding appointments at Macquarie University and the Woolcock Institute. Since 2005 she has published 300 full peer reviewed manuscripts, 4 patents and has attracted more than $20 Million in competitive funding. Daniela sits on the Ab Initio’s board of directors, managing strategic academic-industry partnerships.